Surgical and medical therapy for pancreatic carcinoma

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 3, 2002, Pages 435-455

  Magee, Conor J ^a   Ghaneh, Paula ^a   Neoptolemos, John P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adjuvant therapy; Chemotherapy; Gene therapy; Pancreatic cancer; Radiotherapy; Randomized trials; Surgery

Indexed keywords

CAPECITABINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; FUMAGILLOL CHLOROACETYLCARBAMATE; GEMCITABINE; HEAT SHOCK PROTEIN; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; MARIMASTAT; METHOTREXATE; MITOMYCIN; MITOMYCIN C; ONYX 015; OPIATE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN P16; PROTEIN P53; RAS PROTEIN; THALIDOMIDE; TRASTUZUMAB; UNINDEXED DRUG; VINCRISTINE; CARMUSTINE; GRANULOCYTE COLONY STIMULATING FACTOR; PANCREAS ENZYME; RECOMBINANT DNA; STREPTOZOCIN;

ADENOCARCINOMA; ADVANCED CANCER; ANALGESIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHRONIC PANCREATITIS; DRUG TARGETING; ENDOSCOPIC THERAPY; ENZYME THERAPY; FAMILIAL CANCER; HUMAN; OUTCOMES RESEARCH; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS RESECTION; PATIENT CARE; QUALITY OF LIFE; REVIEW; STENT; ADJUVANT CHEMOTHERAPY; BLEEDING; CANCER PALLIATIVE THERAPY; CANCER STAGING; CLINICAL TRIAL; DIGESTIVE TRACT ENDOSCOPY; DISEASE COURSE; DOSE RESPONSE; DUODENUM OBSTRUCTION; FISTULA; GENE THERAPY; IMMUNOTHERAPY; LAPAROSCOPY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PERFORATION; POSITRON EMISSION TOMOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; PANCREAS TUMOR;

HUMANS; PANCREATIC NEOPLASMS;

EID: 0036598236     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0317     Document Type: Article

References (99)

1. Parkin D M Bray F I Devesa S S Cancer burden in the year 2000. The global picture European Journal of Cancer 37 2001 (suppl 8) 4-66
2. Bramhall S R Allum W H Jones A G et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study British Journal of Surgery 82 1995 111-115
3. Gouma D J van Geenen R C van Gulik T M et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume Annals of Surgery 232 2000 786-795
4. Neoptolemos J P Russell R C Bramhall S et al. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units British Journal of Surgery 84 1997 1370-1376
5. Birkmeyer J D Warshaw A L Finlayson S R et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy Surgery 126 1999 178-183
6. Trede M Schwall G Saeger H D Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality Annals of Surgery 211 1990 447-458
7. Magee C J Greenhalf W Howes N et al. Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications Surgical Oncology 10 2001 1-23
8. Magee C J Ghaneh P Hartley M et al. The role of adjuvant therapy for pancreatic cancer Expert Opinion on Investigational Drugs 11 2002 87-107
9. Neoptolemos J P Dunn J A Stocken D D et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 358 2001 1576-1585
10. Neoptolemos J P Moffitt D D Dunn J A et al. The influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy within the ESPAC-1 randomized controlled trial Annals of Surgery 2001 (in press)
11. Mosca F Giulianotti P C Balestracci T et al. Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy Surgery 122 1997 553-566
12. Sohn T A Yeo C J Cameron J L et al. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators Journal of Gastrointestinal Surgery 4 2000 567-579
13. Smith A C Dowsett J F Russell R C et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction Lancet 344 1994 1655-1660
14. Davids P H Groen A K Rauws E A et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction Lancet 340 1992 1488-1492
15. Knyrim K Wagner H J Pausch J et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct Endoscopy 25 1993 207-212
16. Prat F Chapat O Ducot B et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline Gut 42 1998 76-80
17. Isla A M Worthington T Kakkar A K et al. A continuing role for surgical bypass in the palliative treatment of pancreatic carcinoma Digestive Surgery 17 2000 143-146
18. Lillemoe K D Cameron J L Hardacre J M et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial Annals of Surgery 230 1999 322-328
19. Park K B Do Y S Kang W K et al. Malignant obstruction of gastric outlet and duodenum: palliation with flexible covered metallic stents Radiology 219 2001 679-683
20. Polati E Finco G Gottin L et al. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer British Journal of Surgery 85 1998 199-201
21. Rykowski J J Hilgier M Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief Anesthesiology 92 2000 347-354
22. Gunaratnam N T Sarma A V Norton I D et al. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain Gastrointestinal Endoscopy 54 2001 316-324
23. Leksowski K Thoracoscopic splanchnicectomy for control of intractable pain due to advanced pancreatic cancer Surgical Endoscopy 15 2001 129-131
24. Bruno M J Haverkort E B Tijssen G P et al. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region Gut 42 1998 92-96
25. Stewart C J Mills P R Carter R et al. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases Journal of Clinical Pathology 54 2001 449-455
26. Linder S Blasjo M Sundelin P et al. Aspects of percutaneous fine-needle aspiration biopsy in the diagnosis of pancreatic carcinoma American Journal of Surgery 174 1997 303-306
27. Bhutani M S Hawes R H Baron P L et al. Endoscopic ultrasound guided fine needle aspiration of malignant pancreatic lesions Endoscopy 29 1997 854-858
28. Merchant N B Conlon K C Saigo P et al. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma Journal of the American College of Surgeons 188 1999 421-426
29. Wong T Howes N Threadgold J et al. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients Pancreatology 1 2001 486-509
30. Freeny P C Pancreatic carcinoma: imaging update 2001 Digestive Diseases 19 2001 37-46
31. Balcom J HT Rattner D W Warshaw A L et al. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization Archives of Surgery 136 2001 391-398
32. Friess H Kleeff J Silva J C The role of diagnostic laparoscopy in pancreatic and periampullary malignancies Journal of the American College of Surgeons 186 1998 675-682
33. Povoski S P Karpeh M S Jr Conlon K C et al. Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy Journal of Gastrointestinal Surgery 3 1999 496-505
34. Martignoni M E Wagner M Krahenbuhl L et al. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy American Journal of Surgery 181 2001 52-59
35. Sewnath M E Birjmohun R S Rauws E A et al. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy Journal of the American College of Surgeons 192 2001 726-734
36. Pisters P W Hudec W A Hess K R et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy- associated morbidity in 300 consecutive patients Annals of Surgery 234 2001 47-55
37. Marcus S G Dobryansky M Shamamian P et al. Endoscopic biliary drainage before pancreaticoduodenectomy for periampullary malignancies Journal of Clinical Gastroenterology 26 1998 125-129
38. Lai E C Mok F P Fan S T et al. Preoperative endoscopic drainage for malignant obstructive jaundice British Journal of Surgery 81 1994 1195-1198
39. Pedrazzoli S Beger H G Obertop H et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer Digestive Surgery 16 1999 337-345
40. Seiler C A Wagner M Sadowski C et al. Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results Journal of Gastrointestinal Surgery 4 2000 443-452
41. Tanaka M Sarr M G Role of the duodenum in the control of canine gastrointestinal motility Gastroenterology 94 1988 622-629
42. Tanaka A Ueno T Oka M et al. Effect of denervation of the pylorus and transection of the duodenum on acetaminophen absorption in rats; possible mechanism for early delayed gastric emptying after pylorus preserving pancreatoduodenectomy Tohoku Journal of Experimental Medicine 192 2000 239-247
43. Yeo C J Barry M K Sauter P K et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial Annals of Surgery 218 1993 229-237
44. Halloran, C, M, Ghanch, P, Bosonnet, L, et al. Complications of pancreatic cancer resection, Digestive Surgery in press
45. Pederzoli P Bassi C Falconi M et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery British Journal of Surgery 81 1994 265-269
46. Buchler M Friess H Klempa I et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection American Journal of Surgery 163 1992 125-130
47. Montorsi M Zago M Mosca F et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial Surgery 117 1995 26-31
48. Friess H Beger H G Sulkowski U et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis British Journal of Surgery 82 1995 1270-1273
49. Gouillat C Chipponi J Baulieux J et al. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy British Journal of Surgery 88 2001 1456-1462
50. Lowy A M Lee J E Pisters P W et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease Annals of Surgery 226 1997 632-641
51. Yeo C J Cameron J L Lillemoe K D et al Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial Annals of Surgery 232 2000 419-429
52. Buchler M W Friess H Wagner M et al. Pancreatic fistula after pancreatic head resection British Journal of Surgery 87 2000 883-889
53. Yeo C J Cameron J L Maher M M et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy Annals of Surgery 222 1995 580-588
54. Roder J D Stein H J Bottcher K A et al. Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study Annals of Surgery 229 1999 41-48
55. Ihse I Andren-Sandbery A Surgical treatment: total pancreatectomy In Beger H G (Ed.) Pancreas 1998 1047-1054 Blackwell Science Oxford
56. Pedrazzoli S DiCarlo V Dionigi R et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study Annals of Surgery 228 1998 508-517
57. Halm U Schumann T Schicfke I et al. Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer British Journal of Cancer 82 2000 1013-1016
58. Therasse P Arbuck S G Eisenhauer E A et al. New guidelines to evaluate the response to treatment in solid tumors Journal of the National Cancer Institute 92 2000 205-216
59. Mallinson C N Rake M O Cocking J B et al. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial British Medical Journal 281 1980 1589-1591
60. Frey C Twomey P Keehn R et al. Randomized study of 5-FU and CCNU in pancreatic cancer: report of the Veterans Administration Surgical Adjuvant Cancer Chemotherapy Study Group Cancer 47 1981 27-31
61. Glimelius B Pancreatic and hepatobiliary cancers; adjuvant therapy and management of inoperable disease Annals of Oncology 11 2000 (supplement 3) 153-159
62. Palmer K R Kerr M Knowles G et al. Chemotherapy prolongs survival in inoperable pancreatic carcinoma British Journal of Surgery 81 1994 882-885
63. Burris HA 3rd Moore M J Andersen J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial Journal of Clinical Oncology 15 1997 2403-2413
64. Haycox A Lombard M Neoptolemos J et al. Review article: current treatment and optimal patient management in pancreatic cancer Alimentary Pharmacology and Therapeutics 12 1998 949-964
65. Permert J Hafstrom L Nygren P et al. A systematic overview of chemotherapy effects in pancreatic cancer Acta Oncologica 40 2001 361-370
66. Gunderson L L Martin J K Kvols L K et al. Intraoperative and external beam irradiation ±5-FU for locally advanced pancreatic cancer International Journal of Radiation Oncology, Biology and Physics 13 1987 319-329
67. Ikeda M Okada S Tokuuye K et al. Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy Cancer 91 2001 490-495
68. Ceha H M van Tienhoven G Gouma D J et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma Cancer 89 2000 2222-2229
69. Safran H Moore T Iannitti D et al. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer International Journal of Radiation Oncology, Biology and Physics 49 2001 1275-1279
70. Prott F J Schonekaes K Preusser P et al. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study British Journal of Cancer 75 1997 597-601
71. Yasue M Sakamoto J Yasui K A randomised trial of intraoperative radiation therapy (IORT) vs IORT plus chemotherapy (MTX-5FU) for adenocarcinoma of the pancreas Cancer Research Therapy and Control 3 1993 283
72. Kachnic L A Shaw J E Manning M A et al. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas International Journal of Cancer 96 2001 132-139
73. Beger H G Gansauge F Buchler M W et al. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis Journal of World Surgery 23 1999 946-949
74. Muchmore J H Preslan J E George W J Regional chemotherapy for inoperable pancreatic carcinoma Cancer 78 1996 (supplement 3) 664-673
75. Safran, H, Ramanathan, R, K, Schwartz, J, et al. Herceptin and Gemcitabine for metastatic pancreatic cancers that overexpress Her-2/ neu. In proceedings ASCO Meeting, 2001, San Francisco
76. Halloran C M Ghaneh P Neoptolemos J P et al. Gene therapy for pancreatic cancer-current and prospective strategies Surgical Oncology 9 2000 181-191
77. Lohr M Hoffmeyer A Kroger J et al. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma Lancet 357 2001 1591-1592
78. Ghaneh P Greenhalf W Humphreys M et al. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo Gene Therapy 8 2001 199-208
79. Halloran C M Ghaneh P Neoptolemos J P et al. The effects of combining cytotoxic agents and adenoviral mediated introduction of tumour suppressor genes on pancreatic cells Molecular Therapy 3 2001 S213-S214
80. Boyd M T Vlatkovic N Haines D S A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2 Journal of Biological Chemistry 275 2000 31883-31890
81. Kelley J R Brown J M Frasier M M et al. The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer Surgery 128 2000 353-360
82. Ishikawa O Ohigashi H Imaoka S et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Archives of Surgery 129 1994 1075-1080
83. Coia L Hoffman J Scher R et al. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum International Journal of Radiation Oncology, Biology and Physics 30 1994 161-167
84. Staley C A Lee J E Cleary K R et al. Preopeative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head American Journal of Surgery 171 1996 118-124
85. Spitz F R Abbruzzese J L Lee J E et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas Journal of Clinical Oncology 15 1997 928-937
86. Hoffman J P Lipsitz S Pisansky T et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study Journal of Clinical Oncology 16 1998 317-323
87. White R Lee C Anscher M et al. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas Annals of Surgical Oncology 6 1999 38-45
88. Wanebo H J Glicksman A S Vezeridis M P et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer Archives of Surgery 135 2000 81-87
89. Snady H Bruckner H Cooperman A et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial Cancer 89 2000 314-327
90. Mehta V K Fisher G Ford J A et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas Journal of Gastrointestinal Surgery 5 2001 27-35
91. Breslin T M Hess K R Harbison D B et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Annals of Surgical Oncology 8 2001 123-132
92. Kalser M H Ellenberg S S Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Archives of Surgery 120 1985 899-903
93. Douglass H O Jr Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Gastrointestinal Tumor Study Group Cancer 59 1987 2006-2010
94. Bakkevold K E Arnesjo B Dahl O et al. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicentre study European Journal of Cancer 5 1993 698-703
95. Klinkenbijl J H Jeekel J Sahmoud T et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Annals of Surgery 230 1999 776-782
96. Conlon K C Klimstra D S Brennan M F et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors Annals of Surgery 223 1996 273-279
97. Yeo C J Abrams R A Grochow L B et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Annals of Surgery 225 1997 621-633
98. Neoptolemos J P Group MotUPC Adjuvant radiotherapy and follow-on chemotherapy in patients with pancreatic cancer: results of the UK Pancreatic Cancer study (UKPACA-1) GI Cancer 2 1998 235-245
99. Abrams R A Grochow L B Chakravarthy A et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels International Journal of Radiation Oncology, Biology and Physics 44 1999 1039-1046